MAPT and Alzheimer disease: Treating neurons with purified AD brain-derived Aβ demonstrated that the Exon 4 MAPT−/− neurons were protected from Aβ-driven synapse loss, although 200 pg/ml of AD brain-derived Aβ was insufficient to cause synapse loss in the Exon 1 isogenic panel (Supplementary Fig. 7D).